#HeartFailureAwarenessDays 2022! Information campaign today at Herlev Hospital. Conversations with visitors and employees. Focus on contacting your doctor and getting examined in case of suspect symptoms. #HFAESC HFAPresident Nina Camilla Fuchs Andersen Lærke Nelson

Patient #100 randomized in Empire Prevent Empagliflozin to elderly and obese patients with cardiovascular disease (Empire Prevent): a randomized controlled trial. Collaboration between Research Unit of Cardiology, OUH and Herlev og Gentofte hosp afd for hjertesygdomme.

Empire Prevent 🩵🩷 includes patients in Odense Research Unit of Cardiology, OUH and Copenhagen Herlev og Gentofte hosp afd for hjertesygdomme. We greatly appreciate our collaboration with Steno Diabetes Center Odense and RigsHeart 🫀🚨 🩵🩷

The Empire Prevent trial program marks the first step towards elucidating the potential of SGLT2 inhibition for HF prevention 🫀🫀 Further reading: pubmed.ncbi.nlm.nih.gov/38365073/ Research Unit of Cardiology, OUH Herlev og Gentofte hosp afd for hjertesygdomme RigsHeart 🫀🚨 Julie Hempel Camilla Fuchs Andersen morten schou

OPEN ACCESS: Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial program pubmed.ncbi.nlm.nih.gov/38365073/ #Cardiology